Pure Global

Monitoring of the Influence of Approved PH-therapies RV-PA Coupling - Trial NCT05935865

Access comprehensive clinical trial information for NCT05935865 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Giessen and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05935865
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05935865
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling

Study Focus

Pulmonary Hypertension

Observational

Sponsor & Location

University of Giessen

Giessen, Germany

Timeline & Enrollment

N/A

Feb 13, 2023

Feb 13, 2026

100 participants

Primary Outcome

Afterload,Contractility,Coupling,Validation of Echo/CorLog PV-Loops

Summary

The goal of this observational study is to learn about the acute (days) changes in right
 ventricular functions caused by initiation of pharmacological therapies in patients with
 precapillary pulmonary hypertension. The main question it aims to answer is:
 
 โ€ข Course of afterload and intrinsic contractility throughout the hospital stay Participants
 will be equipped with a device for continuous monitoring and recording of the right
 ventricular pressure signal.

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT05935865

Non-Device Trial